See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
"Muu" projekt MP1GV13026R
MP1GV13026R "BBMRI - tulevikku vaatavad suuremahulised kohordid (1.02.2013−31.01.2017)", Andres Metspalu, Tartu Ülikool, Tartu Ülikooli Eesti Geenivaramu.
MP1GV13026R
BBMRI - tulevikku vaatavad suuremahulised kohordid
BBMRI - Large Prospective Cohorts
BBMRI - Large Prospective Cohorts
1.02.2013
31.01.2017
Teadus- ja arendusprojekt
Muu
ValdkondAlamvaldkondCERCS erialaFrascati Manual’i erialaProtsent
1. Bio- ja keskkonnateadused1.3. GeneetikaB220 Geneetika, tsütogeneetika 1.5. Bioteadused (bioloogia, botaanika, bakterioloogia, mikrobioloogia, zooloogia, entomoloogia, geneetika, biokeemia, biofüüsika jt50,0
3. Terviseuuringud3.11. Terviseuuringutega seotud uuringud, näiteks biokeemia, geneetika, mikrobioloogia, biotehnoloogia, molekulaarbioloogia, rakubioloogia, biofüüsika ja bioinformaatikaB790 Kliiniline geneetika3.1. Biomeditsiin (anatoomia, tsütoloogia, füsioloogia, geneetika, farmaatsia, farmakoloogia, kliiniline keemia, kliiniline mikrobioloogia, patoloogia)50,0
AsutusRiikTüüp
Euroopa Komisjon
PerioodSumma
01.02.2013−31.01.2017464 626,30 EUR
464 626,30 EUR
7.raamprogramm

BBMRI - tulevikku vaatavad suuremahulised kohordid
In recent years, biomedical research has crossed international borders in large, collaborative studies showing the value of multidisciplinarity and scale advantage. This has yielded valuable insights and some led to new and better medicines and treatments for diseases. However, disease-focused studies provide less insight in the real disease onset, the relative disease burden in the population, and the actual comparability of selected patients. Large prospective cohort (LPC) studies following up initially healthy participants for years or decades are considered more reliable and different diseases can be studied. LPC studies require large numbers of subjects which are costly but particularly benefited from the advent of high throughput techniques providing opportunities for powerful study designs. This project unites the large study sets of the European Biobanking and Biomolecular Research Infrastructure (BBMRI) and the International Agency for Research on Cancer (IARC), thus achieving a worldwide unique scale of integration. Specifically, we aim to: 1) Evaluate/improve the harmonization of individual data on health, lifestyle and other exposures; 2) Develop/implement harmonized definitions of diseases; 3) lmprove biobanking and research technologies and develop innovative solutions facilitating high-quality, fair access to samples and data; 4) Provide free transnational access by users, through study proposals selected by an open, pan-European call; 5) ln the framework of these studies, generate and provide access to whole genome sequences, transcriptome, proteome, metabolome and methylome data; 6) Build new public-private partnerships involving large-scale prospective cohorts, and strengthening existing ones, allowing transparent industrial access to academic expertises) Build a network transferring the expertise of established European large-scale biobanks to new biobank initiatives under development in other countries.
TegevusProtsent
Alusuuring30,0
Rakendusuuring60,0
Katse- ja arendustöö10,0